Healixia is the Belgian community of all professionals active along the life cycle of medicines, medical devices, in vitro diagnostics & other health related products. Members are active in research & development (including pre-clinical, early clinical and later phases), medical affairs, safety, regulatory affairs and market access in industry, academia, investigator sites, authorities, regulatory bodies or in consultancy.

Become a member

Healixia events

  1. Online sessie2.jpg
    15 June '21

    Understanding biomarkers in immune therapy

    Webinar

    Speaker: 

    • Yannick Waumans - Global Head Pathology, Imaging and Quantification at CellCarta

  2. Online sessie2.jpg
    18 June '21

    Does price transparency for innovative medicines lead to lower prices?

    Webinar

    Speaker: Prof. Dr. Walter Van Dyck

  3. Online sessie2.jpg
    14 September '21

    Recognition of Pharmaceutical Medicine/Clinical Pharmacology as a specialty for MDs in Belgium: a status update.

    During this webinar, a status update will be provided on the recognition of Pharmaceutical Medicine/Clinical Pharmacology as a specialty for Medical Doctors in Belgium. 

Show all meetings

News

  1. June 10, 2021

    IFAPP Today newsletter

    Source: IFAPP

    Please find here the link to the IFAPP TODAY newsletter of June 2021.

    Read more

  2. June 10, 2021

    Coronavirus: COVID-19 weekly review of side effects from 10 June 2021

    Source: FAMHP

    Coronavirus: wekelijks overzicht bijwerkingen COVID-19-vaccins van 10 juni 2021

    Coronavirus : aperçu hebdomadaire des effets indésirables des vaccins contre la COVID-19 du 10 juin 2021

    Read more

  3. June 7, 2021

    Coronavirus: EMA draws attention to treatment recommendations for suspected thrombocytopenia syndrome (TTS)

    Source: FAMHP

    Coronavirus: EMA vestigt de aandacht op aanbevelingen voor de behandeling bij vermoeden van het trombose trombocytopenie syndroom (TTS)

    Coronavirus : l'EMA attire l'attention sur les recommandations de traitement en cas de suspicion de syndrome de thrombose-thrombocytopénie (TTS)

    Read more

We thank our partners for their support. Click on the logos for more information:
 
digidyco_clinical esolutions_gr_web2.png QbD_logo_RGB_300dpi logo Hebias web.png Modis 440x320 nieuwsbrief.jpg
jsn_logo_jj_vert_color_rgb.jpg 20201210 AxTalis Logo MAx MA.jpg SCIENCETALENTS_LOGO_RGB_POS.png Brookwood Global-website.png